Bridge City Capital’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.71M Sell
66,252
-17,830
-21% -$1.6M 1.58% 19
2025
Q4
$7.34M Sell
84,082
-31,893
-27% -$2.42M 2.16% 6
2025
Q3
$6.64M Buy
115,975
+484
+0.4% +$27.9K 1.77% 13
2025
Q2
$6.82M Sell
115,491
-1,238
-1% -$80K 1.91% 12
2025
Q1
$8.54M Sell
116,729
-146
-0.1% -$12.1K 2.56% 2
2024
Q4
$9.67M Buy
116,875
+8,732
+8% +$689K 2.58% 3
2024
Q3
$7.74M Buy
108,143
+13,783
+15% +$973K 2.13% 4
2024
Q2
$6.46M Buy
94,360
+18,648
+25% +$1.11M 2.17% 6
2024
Q1
$4.06M Buy
75,712
+15,576
+26% +$837K 1.48% 16
2023
Q4
$3.2M Buy
60,136
+7,105
+13% +$346K 1.24% 26
2023
Q3
$2.63M Buy
53,031
+7,410
+16% +$414K 1.33% 25
2023
Q2
$2.72M Buy
45,621
+21
+0% +$1.2K 1.29% 26
2023
Q1
$2.58M Sell
45,600
-167
-0.4% -$10.7K 1.3% 26
2022
Q4
$3.4M Sell
45,767
-322
-0.7% -$21.9K 1.74% 10
2022
Q3
$2.75M Buy
46,089
+1,558
+3% +$93.8K 1.51% 18
2022
Q2
$2.5M Sell
44,531
-73
-0.2% -$4.8K 1.32% 27
2022
Q1
$3.29M Sell
44,604
-215
-0.5% -$14.9K 1.54% 18
2021
Q4
$3.24M Sell
44,819
-3
-0% -$218 1.33% 22
2021
Q3
$3.43M Sell
44,822
-12,056
-21% -$968K 1.56% 16
2021
Q2
$4.41M Sell
56,878
-1,907
-3% -$136K 1.5% 18
2021
Q1
$3.63M Sell
58,785
-625
-1% -$39.6K 1.2% 36
2020
Q4
$3.88M Sell
59,410
-622
-1% -$35.8K 1.47% 19
2020
Q3
$2.97M Sell
60,032
-5,815
-9% -$300K 1.42% 25
2020
Q2
$3.14M Sell
65,847
-10,101
-13% -$487K 1.44% 20
2020
Q1
$3.23M Buy
75,948
+9,312
+14% +$460K 1.56% 18
2019
Q4
$3.92M Buy
66,636
+9,605
+17% +$521K 1.61% 16
2019
Q3
$2.92M Buy
57,031
+12,380
+28% +$590K 1.26% 27
2019
Q2
$1.89M Buy
44,651
+220
+0.5% +$9.55K 1.04% 41
2019
Q1
$2.19M Sell
44,431
-347
-0.8% -$15.7K 1.28% 27
2018
Q4
$1.94M Buy
44,778
+4,806
+12% +$240K 1.26% 29
2018
Q3
$2.27M Sell
39,972
-1,701
-4% -$89.5K 1.41% 21
2018
Q2
$2.1M Sell
41,673
-1,392
-3% -$72.6K 1.33% 23
2018
Q1
$2.15M Buy
43,065
+2,292
+6% +$108K 1.44% 21
2017
Q4
$1.68M Hold
40,773
1.22% 35
2017
Q3
$1.21M Buy
40,773
+3,262
+9% +$99.6K 0.91% 57
2017
Q2
$1.24M Buy
+37,511
New +$1.18M 1.04% 45

Other funds holding GMED